FDA approves Lilly's Zepbound (tirzepatide) for chronic weight managementThe FDA has approved Eli Lilly and Company's Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that...
Apollo’s ESG and REVISE Systems approved by FDAApollo Endosurgery has been granted marketing authorisation for its ESG, ESG Sx, REVISE and REVISE Sx through the FDA’s De Novo...
Spatz Medical’s first adjustable gastric balloon, the Spatz3 Gastric Balloon, approved in USThe FDA has approved the Spatz Medical’s Spatz3 Gastric Balloon, the first adjustable gastric balloon system, to aid in weight loss for...
FDA approves Novo Nordisk’s Wegovy (semaglutide 2.4 mg) for weight managementThe FDA has approved Novo Nordisk’s Wegovy (the brand name for once-weekly semaglutide 2.4mg injection in the US) for chronic weight...
LSG and RYGB-induced upregulation of apoA-IV is beneficial for insulin secretion and energy expenditure2 days ago
Tirzepatide reduced sleep apnoea severity by up to nearly two-thirds in adults living with OSA and obesity2 days ago